Developing CardiolRx^TM for the rapidly growing medicinal cannabinoids market.

Cardiol is planning an international clinical study of acute myocarditis, the most common cause of sudden cardiac death in people under 35 years of age.

Committed to conquering a serious condition that affects more than 26 million people globally.